Detect invasive fungal infections early with the accurate Serum Galactomannan test.
The Serum Galactomannan test is a diagnostic blood test used to detect the presence of galactomannan, a component of the cell wall of the Aspergillus fungus. This test is primarily used to identify invasive aspergillosis, a serious fungal infection that affects immunocompromised individuals, such as those undergoing chemotherapy, organ transplantation, or long-term corticosteroid therapy. By detecting galactomannan in the blood, the test helps in the early diagnosis of fungal infections, enabling prompt medical intervention.
The test is recommended for individuals who are at high risk of developing fungal infections, particularly invasive aspergillosis. This includes Patients with weakened immune systems due to cancer treatments, bone marrow transplants, or advanced HIV/AIDS. Individuals undergoing organ transplantation and receiving immunosuppressive drugs. Patients with prolonged neutropenia (low white blood cell count) or those in critical care settings. People show symptoms such as persistent fever, respiratory distress, or unexplained infections that do not respond to antibiotics.
The Serum Galactomannan test is crucial for the early detection and management of invasive aspergillosis. This condition can progress rapidly and lead to severe complications if not treated promptly. Early diagnosis through this test enables targeted antifungal therapy, reducing the risk of complications and improving survival rates. It also helps differentiate fungal infections from bacterial or viral ones, ensuring appropriate treatment. Monitoring galactomannan levels can also assess treatment response and disease progression.
The results of the Serum Galactomannan test are reported as an index value:
Negative: Less than 0.5 – indicates the absence of detectable galactomannan, ruling out active Aspergillus infection.
Indeterminate: 0.5 to 0.79 – may require repeat testing or additional diagnostics for confirmation.
Positive: 0.8 or higher – suggests the presence of an active Aspergillus infection, requiring immediate medical attention.
You should choose Diagnopein for your Serum Galactomannan test because we are committed to providing high-quality diagnostic care in a clean and hygienic environment. Our center is equipped with advanced technology to ensure accurate and reliable test results, which are crucial for assessing this test. Diagnopein’s experienced staff is dedicated to handling tests with precision and care, offering you both expertise and comfort. We also offer affordable pricing, making essential health diagnostics accessible without compromising quality. For timely, professional, and affordable cardiac testing, Diagnopein is your trusted partner for your healthcare.
Yes, serial testing can help track the effectiveness of antifungal treatment and monitor disease progression.
The test involves a simple blood draw, with the sample analyzed in the laboratory for the presence of galactomannan.
While it is highly sensitive for Aspergillus, false positives can occur in patients using certain antibiotics or consuming foods containing galactomannan.
Results are usually available within 24 to 48 hours, depending on the diagnostic center.